Advancing Data-Driven Innovation in Digital Health Through the DIGILUNG Project
Cognuse is an established player in the digital health domain, with long-standing experience in delivering impactful solutions across clinical, research, and rehabilitation settings. Their expertise makes then a trusted partner in multidisciplinary R&D collaborations, particularly those focused on disease monitoring for chronic and critical conditions, digital therapeutics, and patient pathway optimization.
In DIGILUNG project, Cognuse contributes as a data aggregation provider. Invited to the consortium based on prior partnerships and domain expertise, their role centered on developing the Curated Data Module (CDM). This secure and flexible module enables seamless data sharing among project partners, while integrating emerging services from cloud providers. The core principle behind CDM is to maintain adaptability and joint data ownership across institutional boundaries – a crucial step toward future-proofing digital healthcare infrastructure.
While Cognuse’s specific tasks within DIGILUNG have been successfully completed, the outcomes reinforce their broader mission: to enable practical, scalable solutions that align with the real-world needs of healthcare providers.
Supporting Healthcare Institutions with Tangible Impact
In all their work, Cognuse prioritizes measurable benefits for hospitals and clinics. They design solutions that align with daily clinical realities and reduce duplication in documenting clinical and nursing processes. This ensures a smoother integration of new tools into existing workflows and supports better care outcomes.
Building on Past Achievements
VUB’s involvement builds on a strong foundation of previous research in medical imaging and AI. The university has developed advanced methods for AI-driven medical image registration and lesion classification, including work on COVID-19 diagnostics. These capabilities are now being adapted for more robust and clinically relevant tools for detecting and monitoring lung diseases within the DIGILUNG project.
Moreover, VUB brings valuable experience in ethical AI and medical regulation, currently applied to guide the ethical-legal framework that supports DIGILUNG’s compliance with medical standards and prepares it for clinical implementation.
A unique aspect of VUB’s expertise comes from previous research into gait analysis using inertial sensors. These AI-based methods, originally designed to detect early signs of motor impairments in elderly and neurological populations, are now being repurposed for the analysis of respiratory signals from wearable devices like the LungShirt. This interdisciplinary approach demonstrates how foundational work in one field can successfully drive innovation in another.
A Strong Network for International Collaboration
Cognuse is proud to be a connector within the Estonian and European digital health ecosystem, and beyond. Their work spans multiple countries, including the UK (including Northern Ireland), Germany, Estonia, and Lithuania. They also maintain strategic partnerships in the United States, Singapore, and other global markets. This network positions theme to engage in wide-ranging collaborations, grounded in the belief that many healthcare challenges—and their solutions—are inherently global.
Looking Ahead: Real-World Application Through Hospital Collaboration
As a company focused on delivering innovative solutions to medical institutions, Cognuse would like to involve hospitals and clinics in the development and testing phases.
Partnering with these healthcare providers will allow to evaluate Digilung in real-world clinical settings, enabling broader testing and a deeper understanding of how it can be effectively applied to COPD treatment on a larger scale.
By involving medical institutions in testing and implementation, they ensure that solutions like DIGILUNG are clinically relevant and truly beneficial for patients, particularly in the context of COPD treatment and other chronic respiratory conditions.
The project is funded by the European Union. The expressed views and opinions belong solely to the author(s) and may not necessarily reflect the views of the European Union or EISMEA. Neither the European Union nor the funding institution can be held responsible for the expressed views.